Laboratórios Wyeth Whitehall

Pfizer: One of the world's premier biopharmaceutical companies - - Search JobsStudent & Early CareerPfizer365.comOur Hiring & Recruiting ProcessConnect With UsInvestorsEvents & PresentationsFinancialsInvestor NewsStock InformationGovernanceShareholder ServicesNewsPartners      Wellness Hot Topics Hot Topics Greta's Special Heart Our Science Product Pipeline Clinical Trials Collaboration Research sites Our People Diverse Perspectives Our Purpose Protecting the Environment Positions on Health Policies Patient Assistance Programs Grants Hot Topics Pharma Meets Fashion #Cancerland Our Products Distributors Material Safety Data Sheets Medical Information Contacts Our Purpose Our PurposePharma Meets Fashion at NYFW ShowCommitted to increasing conversation and reducing mortality rates, #Cancerland brought research to the runway at a recent New York Fashion Week show.Learn More Home page Your Health Greta’s Special Heart The family of a young heart recipient talks about celebrating life and how they’re preparing for the road ahead. Read More Find a TrialSearch for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you. Condition, Keyword, or NCT Number Location Advanced Search Your Health What is Wellness? Making lifestyle choices that include healthy habits can help achieve wellness. Learn More Search products Search products, A–ZOver-the-Counter productsPrescription products  Our Science This Is What Happens to Your Body in Space The journey to Mars may still be decades away, but getting there requires a new level of understanding about how extended travel through space affects the human body. Learn More Our Purpose Meet Terry, Helped by Pfizer RxPathways Pfizer RxPathways connected Terry to assistance, and he’s grateful Pfizer was able to help him. Read More Our People Connected Thoughts: Sean Hudson He's had 23 years of experience with healthcare companies since earning his MBA. Read More Latest news Pfizer Receives Breakthrough Therapy Designation. Pfizer Inc. (NYSE:PFE) today announced its once-daily oral Janus kinase 1 (JAK1) inhibitor PF-04965842 received Breakthrough Therapy designation from the U.S. Food and Drug Administration . . . Read more